The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Stepanova E.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Sudarev P.A.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Yanyushkina E.S.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Abramenko A.S.

M. F. Vladimirsky Moscow Regional Research Clinical Institute

Garova E.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Larionova E.V.

L.I. Sverzhevsky Scientific Research Clinical Institute of Otorhinolaryngology

The effectiveness of transtympanic use of dexamethasone 4 mg in Meniere’s disease, severe and moderate course of the disease

Authors:

Kryukov A.I., Kunelskaya N.L., Garov E.V., Stepanova E.A., Sudarev P.A., Yanyushkina E.S., Abramenko A.S., Garova E.E., Larionova E.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(1): 21‑26

DOI: 10.17116/otorino20228701121

Read: 5613 times

Contact the author
Table of contents

THE EFFECTIVENESS OF TRANSTYMPANIC USE OF DEXAMETHASONE 4 MG IN MENIERE’S DISEASE, SEVERE AND MODERATE COURSE OF THE DISEASE
THE EFFECTIVENESS OF TRANSTYMPANIC USE OF DEXAMETHASONE 4 MG IN MENIERE’S DISEASE, SEVERE AND MODERATE COURSE OF THE DISEASE

To cite this article:

Kryukov AI, Kunelskaya NL, Garov EV, et al. The effectiveness of transtympanic use of dexamethasone 4 mg in Meniere’s disease, severe and moderate course of the disease. Russian Bulletin of Otorhinolaryngology. 2022;87(1):21‑26. (In Russ.)
https://doi.org/10.17116/otorino20228701121

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis of laby­rinth hydrops in patients on different stages of Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(3):24-29
Endaural phonoelectrophoresis with dexa­methasone in the treatment of Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(6):19-23
Role of platelet-rich plasma in mana­gement of sensorineural hearing loss diseases. Russian Bulletin of Otorhinolaryngology. 2026;(1):4-10
Dyna­mics of permeability of the blood-brain barrier after FUS thalamotomy acco­rding to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60
Role of magnetic reso­nance imaging in dete­cting the signs of inte­rnal caro­tid artery stenosis in the acute period of athe­rothrombotic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):67-73
Sili­cone lymphadenopathy is a rare complication of breast implant rupture. Plastic Surgery and Aesthetic Medi­cine. 2025;(3):30-37
Diffusion tensor magnetic reso­nance imaging in the evaluation of reco­nstructive craniopalisty resu­lts in children with sagi­ttal syno­stosis. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(3):5-11
Loca­lization of neurovascular conflict in trigeminal neuralgia. Burdenko's Journal of Neurosurgery. 2025;(5):37-44
Primary vasculitis of the intracranial arte­ries and cere­brovascular diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):5-12
Variant anatomy of pude­ndal nerve and Alcock’s canal in mature women acco­rding to magnetic reso­nance imaging. Russian Journal of Operative Surgery and Clinical Anatomy. 2026;(1):5-12
Abstract:

The results of transtympanic administration of 4 mg dexamethasone in 37 patients with moderate and severe Meniere’s disease are presented. The endolymphatic hydrops was detected in all inner ear structures with predominant accumulation in vestibule and semicircular canals by MRI-visualization before therapy. After 1 month of 4 mg dexamethasone transtympanic therapy the hydrops degree decreased. Daily transtympanic administration of 4 mg dexamethasone for a month leads to reduction of vertigo attacks duration and expression in 92% of cases (follow-up period 24 months) and can be considered when conservative therapy is ineffective before destructive surgical interventions.

Keywords:

Meniere’s disease
endolymphatic hydrops
magnetic resonance imaging
contrast substance
vertigo attack

Authors:

Kryukov A.I.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Kunelskaya N.L.

L. I. Sverzhevsky Research Clinical Institute of Otorhinolaryngology;
Pirogov Russian National Research Medical University

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Stepanova E.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Sudarev P.A.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Yanyushkina E.S.

Sverzhevskiy Research Clinical Institute of Otorhinolaryngology

Abramenko A.S.

M. F. Vladimirsky Moscow Regional Research Clinical Institute

Garova E.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Larionova E.V.

L.I. Sverzhevsky Scientific Research Clinical Institute of Otorhinolaryngology

Received:

12.05.2021

Accepted:

20.06.2021

Close metadata

References:

  1. Kryukov AI, Kunelskaya NL, Garov EV, Belyakova LV, Baybakova EV, Yanyushkina ES, Zagorskaya EE, Levina YuV, Guseva AL, Chugunova MV, Kudeeva YaYu, Karneeva OV, Kirichenko IM. Bolezn’ Men’era. Klinicheskie rekomendatsii. M.—SPb; 2014. (In Russ.).
  2. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A; Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Journal of Vestibular Research. 2015;25(1):1-7.  https://doi.org/10.3233/ves-150549
  3. Palchun VT, Levina YuV. Dissection of the endolymphatic duct in Meniere’s disease. Vestnik otorinolaringologii. 2003;3:4-6. (In Russ).
  4. Palchun VT, Kadymova MI, Belyakova LV, Polyakova TS, Luchikhin LA, Magomedov MM, Ivanets IV, Ogorodnikov DS, Derevyanko SN. Taktika i vybor metoda lecheniya bol’nykh Bolezn’yu Men’era na osnovanii otdalennykh rezul’tatov. Posobie dlya vrachej. M. 2000. (In Russ.). https://doi.org/10.1097/00129492-200403000-00011
  5. Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Meniere’s disease. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2018;135(1):29-32.  https://doi.org/10.1016/j.anorl.2017.12.006
  6. Magnan J, Özgirgin ON, Trabalzini F, Lacour M, Escamez AL, Magnusson M, Güneri EA, Guyot JP, Nuti D, Mandalà M. European position statement on diagnosis, and treatment of Meniere’s disease. The Journal of International Advanced Otology. 2018;14(2):317-321.  https://doi.org/10.5152/iao.2018.140818
  7. Kryukov AI, Kunelskaya NL, Shershunova EA, Rebrov IE, Yamshchikov VA, Garov EV, Mishchenko VV. Topical administration of drugs into the inner ear. The current state of the problem and prospects of development. Vestnik otorinolaringologii. 2019;84(5): 6-14. (In Russ). https://doi.org/10.17116/otorino2019840516
  8. Instruktsiya dlya meditsinskogo primeneniya lekarstvennogo preparata Deksametazon. Accessed December 22, 2021. (In Russ.). https://www.rlsnet.ru/mnn_index_id_915.htm
  9. Bird PA, Murray DP, Zhang M, Begg EJ. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otology and Neurotology. 2011;32(6):933-936.  https://doi.org/10.1097/MAO.0b0113e3182255933
  10. Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngology — Head and Neck Surgery. 1996;115(1): 38-41.  https://doi.org/10.1016/S0194-5998(96)70133-X
  11. Nevoux J, Viengchareun S, Lema I, Lecoq A-L, Ferrary E, Lombes M. Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflugers Archiv. 2015;467(9):1931-1943. https://doi.org/10.1007/s00424-014-1629-5
  12. Takeda T, Taguchi D. Aquaporins as potential drug targets for Meniere,s disease and its related diseases. Handbook of Experimental Pharmacology. 2009;(190):171-184.  https://doi.org/10.1007/978-3-540-79885-9_8
  13. Eckhard A, Gleiser C, Arnold H, Rask-Andersen H, Kumagami H, Muller M, Hirt B, Lowenheim H. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Molecular Aspects of Medicine. 2012;33(5-6):612-637.  https://doi.org/10.1016/j.mam.2012.06.004.
  14. Dong SH, Kim SS, Kim SH, Yeo SG. Expression of aquaporins in inner ear disease. Laryngoscope. 2020;130(6):1532-1539. https://doi.org/10.1002/lary.28334
  15. Boyko NV, Kunelskaya NL. Modern problems of Meniere’s disease. Vestnik otorinolaringologii. 2016;81(5):89-93. (In Russ.). https://doi.org/10.17116/otorino201681589-93
  16. Ishiyama G, Lopez IA, Beltran-Parrazal L, Ishiyama A. Immunohistochemical localization and mRNA expression of aquaporins in the macula utriculi of patients with Meniere’s disease and acoustic neuroma. Cell and Tissue Research. 2010;340(3):407-419.  https://doi.org/10.1007/s00441-010-0975-7
  17. Ishiyama G, Lopez I, Sepahdari A, Ishiama A. Meniere’s disease: histopathology, cytochemistry, and imaging. Annals of the New York Academy of Sciences. 2015;1343:49-57.  https://doi.org/10.1111/nyas.12699
  18. Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope. 2007;117(3):415-420.  https://doi.org/10.1097/MLG.0b013e31802c300c
  19. Kryukov AI, Kunelskaya NL, Garov EV, Stepanova EA, Baybakova EV, Yanyushkina ES, Abramenko AS. Sposob opredeleniya stepeni endolimfaticheskogo gidropsa pri Bolezni Men’era, vybor taktiki lecheniya i otsenka ego effektivnosti. Patent RU 2630129 C1 ot 05.09.2017. Byull. №25. (In Russ.). Accessed December 22, 2021. https://www.fips.ru
  20. Nakashima T, Naganawa S, Pyykko I, Gibson WP, Sone M, Nakata S, Teranishi M. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Oto-Laryngologica. Supplementum. 2009;560:5-8.  https://doi.org/10.1080/00016480902729827
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.